bufomix easyhaler 160 µg/dosis - 4.5 µg/dosis inhalatiepdr. multidos. cont.
orion corp. - budesonide 160 µg/dosis; formoterolfumaraatdihydraat 4,5 µg/dosis - inhalatiepoeder - 160 µg/dose - 4,5 µg/dose - budesonide 160 µg/dosis; formoterolfumaraatdihydraat 4.5 µg/dosis - formoterol and budesonide
bufomix easyhaler 320 µg/dosis - 9 µg/dosis inhalatiepdr. multidos. cont.
orion corp. - budesonide 320 µg/dosis; formoterolfumaraatdihydraat 9 µg/dosis - inhalatiepoeder - 320 µg/dose - 9 µg/dose - budesonide 320 µg/dosis; formoterolfumaraatdihydraat 9 µg/dosis - formoterol and budesonide
bufomix easyhaler 80 µg/dosis - 4.5 µg/dosis inhalatiepdr. multidos. cont.
orion corp. - budesonide 80 µg/dosis; formoterolfumaraatdihydraat 4,5 µg/dosis - inhalatiepoeder - 80 µg/dose - 4,5 µg/dose - budesonide 80 µg/dosis; formoterolfumaraatdihydraat 4.5 µg/dosis - formoterol and budesonide
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - calcium homeostase - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
tramadol/paracetamol krka 75 mg - 650 mg filmomh. tabl.
krka d.d. novo mesto d.d. - paracetamol 650 mg; tramadolhydrochloride 75 mg - eq. tramadol 65,88 mg - filmomhulde tablet - 75 mg - 650 mg - tramadolhydrochloride 75 mg; paracetamol 650 mg - tramadol and paracetamol
tramadol/paracetamol ab 37.5 mg - 325 mg filmomh. tabl.
aurobindo sa-nv - paracetamol 325 mg; tramadolhydrochloride 37,5 mg - filmomhulde tablet - 37,5 mg - 325 mg - tramadolhydrochloride 37.5 mg; paracetamol 325 mg - tramadol and paracetamol
tramadol/paracetamol eg 37.5 mg - 325 mg filmomh. tabl.
eg sa-nv - paracetamol 325 mg; tramadolhydrochloride 37,5 mg - filmomhulde tablet - 37,5 mg - 325 mg - tramadolhydrochloride 37.5 mg; paracetamol 325 mg - tramadol and paracetamol
tramadol/paracetamol teva 37.5 mg - 325 mg filmomh. tabl.
teva pharma belgium sa-nv - tramadolhydrochloride 37,5 mg; paracetamol 325 mg - filmomhulde tablet - 37,5 mg - 325 mg - paracetamol 325 mg; tramadolhydrochloride 37.5 mg - tramadol and paracetamol
tramadol/paracetamol krka 37,5 mg/325 mg filmomhulde tabletten
krka d.d., novo mesto smarjeska cesta 6 8501 novo mesto (sloveniË) - paracetamol 325 mg/stuk ; tramadolhydrochloride 37,5 mg/stuk samenstelling overeenkomend met ; tramadol 32,9 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 400 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; polysorbaat 80 (e 433) ; titaandioxide (e 171) ; zetmeel, gepregelatineerd, cellulose, microkristallijn (e 460) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 400 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; polysorbaat 80 (e 433) ; titaandioxide (e 171) ; zetmeel, gepregelatineerd, - tramadol and paracetamol
tramadol/paracetamol 37,5/325 mg focus, filmomhulde tabletten
focus care pharmaceuticals b.v. westzijde 416 1506 gm zaandam - paracetamol ; tramadolhydrochloride samenstelling overeenkomend met ; tramadol - filmomhulde tablet - cellulose, microkristallijn (e 460) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 400 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; polysorbaat 80 (e 433) ; titaandioxide (e 171) ; zetmeel, gepregelatineerd, cellulose, microkristallijn (e 460) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 400 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; polysorbaat 80 (e 433) ; titaandioxide (e 171) ; zetmeel, gepregelatineerd, - tramadol and paracetamol